<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><description>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 04 Mar 2021 16:34:25 +0800</pubDate><image><url>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</url><title>Insight数据库 | wechat-feeds</title><link>http://MzA4MzkzMDYyNw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>荣昌生物 1 类新药「泰它西普」即将获批</title><link>https://mp.weixin.qq.com/s/Qdo21GhutkXaZh0sj5WbZA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8GoqrZFSlPAqjVafmuqqyjCaMWhppOmZhWXULJ3iaeag8iaJk3kTBIJag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>贝达药业三代 EGFR 抑制剂报上市，四代在路上，肺癌靶向药组合发力！</title><link>https://mp.weixin.qq.com/s/K4AeW763zy7t6Sb_DhgRxA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8l7MB670MRkm84HbLZlPAIq17s2eicSTAuAh7vOmM0icb5l9gUxjbBa2w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>斑秃患者福音！礼来 JAK 抑制剂 3 期临床达到主要终点</title><link>https://mp.weixin.qq.com/s/kqNbYRqaiXKPwlaO_a4Ynw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8XeL0c1sbYQtJwm2pl9ffAD7nLDMRuCCDiavVls7iaGCMy0EKp2y9EF6A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>首个国产 PD-1 在 FDA 递交上市申请！来自君实生物</title><link>https://mp.weixin.qq.com/s/7HuJhALhuJQnEbPXPPmBww</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa5RlyS5mMCy25smHc8ucp8iasqcMOPEQKouPS2mUo96uUicCN3yzezfZ0DGrsYUrbCsTDibyAgxomJw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Thu, 04 Mar 2021 14:12:04 +0800</pubDate></item><item><title>牵手阿斯利康，君实生物能否完成逆袭？</title><link>https://mp.weixin.qq.com/s/nZSlEM-Hydq9oanjQ8jQAQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv4J6wsgV5OH4kBpjbNQbsgSFBUicFdmEYwd69NOSz7g0EDXeFmPWGEN3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>第 2 款国产三代 EGFR 抑制剂！艾力斯医药「伏美替尼」获批上市</title><link>https://mp.weixin.qq.com/s/_j57BLYbpbCAhRaoNS_-nQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv42j9nYYtpjJLvqZ1icsTacQ7SNFnm3EicoqeDGEadxpkJeicjPhzJesXQw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>首仿！恒瑞医药「托伐普坦」获批上市</title><link>https://mp.weixin.qq.com/s/nhqgWXdIweROqcSoLPwj2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv41w1J38HxtiaeI5xq8LE6liaHVHBYQt8TZ63VLQ5icetRb0SuvUPX3NlXw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>贝达药业 PI3K-α 抑制剂获批临床</title><link>https://mp.weixin.qq.com/s/wdK6XQlSzp9Gd8o0PF7j8A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv4bn80SowZibSJJUPPjHw7Ty0FQg9n4hiaoMRiat4k1tTugK5zrCuvtMgDA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>取得第 4 个国家上市许可，百济神州「泽布替尼胶囊」加拿大获批</title><link>https://mp.weixin.qq.com/s/piZAUCm0lOPpVAtvMPSEpA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZa4WQ2cGuCHluPL5ibt7tfv4UVH6ab5tJ55Rrrh1iaSTmGMC9QOWfeehxqoPpXBgyPuhK9humrkicpCg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Wed, 03 Mar 2021 16:15:10 +0800</pubDate></item><item><title>晚期肝癌，指南推荐了这些靶向药和免疫疗法</title><link>https://mp.weixin.qq.com/s/Lm0K2_yJJgsYj2kYZiXBZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycBtE31TtkRnwmU7w47qWOxTs7qWuJ2wII3NbPicMmAEefdMA18j4GibWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight 数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>获批一年半，默沙东宣布撤回 K 药小细胞肺癌适应症</title><link>https://mp.weixin.qq.com/s/pSXQ-D5ELUdP72Wv7tKZtA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYWmRmAzr1kqOfodGWD10U8ias590mEmEYztd1IrP5zicQUvvUMqSk3c5ZLInISnQGprFp97BXBT1Gg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>信立泰质量负责人、副总经理赵万顺辞职，曾履职拜耳、扬子江等企业</title><link>https://mp.weixin.qq.com/s/O744gHb1x9nC7wavtUgk8w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYWmRmAzr1kqOfodGWD10U8I6pFfW8ACLPEusgkuyJ8z2Fk7ENhD3fXic5T02YRDf9cGvpwsMsU7AQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>重磅：30亿+规模注射用头孢曲松钠首家新增适应症过评，金城金素强势来袭！</title><link>https://mp.weixin.qq.com/s/b2hY4qQRY8T6ERfTls_kLw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/8J9UGoucicIRvZVO5Hh8OTBLvKt19szicVsLAHzsrqKpBJdXpSf7GoETjXR4u7jjglz6P4qOCiadwx3AQJ5pMun7w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>重磅：30亿+规模注射用头孢曲松首家增适应症过评！！]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:34:07 +0800</pubDate></item><item><title>上市到进医保中位数 1.8 年！2020 医保目录正式执行，最全谈判价格曝光（附 Excel 下载）</title><link>https://mp.weixin.qq.com/s/ngvCHfM6_4X6VpK59Plj_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfyc6m3lg6bouqodibquGJdhGNff9klviaYD20INpSCr9DFzyPO1apFbNmWQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>默沙东 CTLA-4 单抗国内获批临床，2 亿美元从康方生物引进</title><link>https://mp.weixin.qq.com/s/hlc6QKvYxhDPiulhL1UD4Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycvF9l6wocnycsIUgzCP6Bpg6GibYIKBiaIXMJdp9PbEtBPwlHmSh6E09w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>百济神州 PD-1降价 80% 进医保，今日正式执行</title><link>https://mp.weixin.qq.com/s/Eugk-asqI8Em2zP_jb-81Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycbR3iaOrWiaia2XJcI8Ta3OuYCGXL8ib3HULiaFjDZ0KyYiac6nB5O3bDRk2g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>复星医药高管变动！副总裁陈战宇离职，李东久继任</title><link>https://mp.weixin.qq.com/s/RhzIqrdfn4ABrWG2KAE3Gw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZaHmkHykcIpFQHDHp3DWfycoiao8FoquTAYgU0KSTvVOujODcnsaKCs05ztK3tKPq5E7tRfM0uVTOg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>药研论坛｜药品注册现场核查及M4注册申报文件撰写与递交专题培训</title><link>https://mp.weixin.qq.com/s/pXkeGwmeWy9_emPEX5j46Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/icVUq9ICDeI1NHiaqP537zXOXia0EuEt6pHG4AlicshLQTko7ia7Gib3icr4ibjhbDPU54EKbVNjeWaXB3r7SwosiaRQpSQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年3月20~21（周六日）地点：南京曙光国际大酒店]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:12 +0800</pubDate></item><item><title>本周 25 个仿制药通过一致性评价，七成为注射剂</title><link>https://mp.weixin.qq.com/s/5iAwOwDNLFbIlk_t3Cm6jA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBK5PGHQPC4Z90zPw7wuRS0yroJjonaLwNFicTY34qCFLZ9kj6XztQk0Lg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Insight数据库]]></content:encoded><pubDate>Sun, 28 Feb 2021 03:36:29 +0800</pubDate></item><item><title>「治愈」癌症需百万，中国首个 CAR-T 药物或将上市</title><link>https://mp.weixin.qq.com/s/sKg9cEhNe6pUjaQo3IM9-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/5dTQk9tMvZYQywZiatU7u6aiajTmw4ZbBKfWx20FH5mWhcI5zqgb859yr7U3Z9RpzwuOpKnianTJNVnc7gNAXOdag/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这款新药，可能「治愈」也可能「杀死」一名无药可用的癌症患者，怎么选？]]></content:encoded><pubDate>Fri, 26 Feb 2021 18:34:40 +0800</pubDate></item></channel></rss>